Your browser doesn't support javascript.
loading
A Systematic Literature Review of the Clinical Presentation, Management, and Outcome of Gestational Gigantomastia in the 21st Century.
Alhindi, Nawaf; Mortada, Hatan; Alzaid, Wasan; Al Qurashi, Abdullah A; Awan, Basim.
Afiliação
  • Alhindi N; Faculty of Medicine, King Abdulaziz University, P.O. BOX: 23456, Rabigh, Saudi Arabia. Nalhindi0010@stu.kau.edu.sa.
  • Mortada H; Division of Plastic Surgery, Department of Surgery, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
  • Alzaid W; Department of Plastic Surgery & Burn Unit, King Saud Medical City, Riyadh, Saudi Arabia.
  • Al Qurashi AA; Faculty of Medicine, Jouf University, Al-Jawf, Saudi Arabia.
  • Awan B; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Aesthetic Plast Surg ; 47(1): 10-29, 2023 02.
Article em En | MEDLINE | ID: mdl-35941388
ABSTRACT

BACKGROUND:

Gestational gigantomastia (GG) is an uncommon pregnancy condition, and the underlying cause of GG has yet to be determined. Medical management and surgery are two treatment options for GG, and breast reduction or mastectomy with delayed reconstruction is the only available surgical option. We have conducted this systematic review to summarize and critically analyze all the GG data in the literature.

METHODS:

The preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines were adhered to in reporting this article. A systematic search was conducted in February 2022 for published case reports and case series on GG using the PubMed, MEDLINE, and Cochrane databases. The following keywords were used macromastia, gestational gigantomastia, and gestational.

RESULTS:

A total of 639 articles were searched, and only 66 case reports published between 1962 and 2022 were included. The mean patient's age at presentation was 28.79 years old. The majority of the patients were in their first trimester (n = 23, 47%). The main complaint was rapid bilateral breast enlargement (n = 54, 80.59%). Bromocriptine was the most common medical management used (n = 19/35, 54.28%). Bilateral breast reduction was the most common surgery (n = 24/48, 50%). Most patients had uneventful recovery (n = 40/54, 74.07%).

CONCLUSION:

Gigantomastia is a difficult condition, in terms of its management. We have found that surgery is the gold-standard among all the cases reported; while Bromocriptine was the most commonly administered medical therapy. This systematic review provides a guideline for plastic surgeons to better facilitate their care of these patients. LEVEL OF EVIDENCE III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Guideline / Systematic_reviews Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamoplastia Tipo de estudo: Guideline / Systematic_reviews Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Aesthetic Plast Surg Ano de publicação: 2023 Tipo de documento: Article